Archive | Life Science ETF’s and Mutual Funds

Biotech Bull Market: Top ETFs Outperform Mutual Funds Over 2 Years

Can Healthcare/Biotechnology Funds Outperform ETFs in 2015? In January of 2013 we compared three of the most liquid life science ETFs to some of the top mutual funds in the sector. Review our 2013 summary but the conclusion at that time was that ETFs provided better returns than mutual funds over a five year period […]

Continue Reading 0

Cruise Control Till Year End

Update 12/12 Or Maybe NOT!! Jobs data tomorrow and most funds will ride their positions through year end. In the meantime it is a traders market. Update next week but review all our portfolio picks.

Continue Reading 0

Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN

Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market  YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is […]

Continue Reading 0

Rayno Life Science Stocks: Be An Investor Not A Trader…Update-1

Update-1 …After 1.94% NASDAQ Sell-Off All three market indices got crushed today with a downdraft attributed to ending of QE, rising i rates in 2015, a rising dollar and just plain profit taking. A 3.8% hit on Apple (AAPL) did not help support the QQQ which also holds many large cap biotech stocks.The healthcare sector […]

Continue Reading 0

Rayno Life Science: Trading Notes End of August

As we move into a heavier trading period watch your portfolio for changes as volume picks up. Here are some of our long term portfolio winners where you can take profits: Exact Sciences (EXAS) short squeeze took it to $22. Illumina (ILMN) triple to at $180. Here are a few laggard stocks with bullish momentum: […]

Continue Reading 0

August Rally Fading-Buyers On Hold in Light Summer Trading:Top Pick FBT

Large Caps Rule Macro and Seasonal Risks Create a Choppy Market The August biotech rally has taken us to the midpoint of the February top and May bottom and is faltering. Look at the XBI SPDR S&P biotech ETF (XBI), a proxy for momentum and smaller cap trading, up 8.7% over 30 days despite a […]

Continue Reading 0

Biotechnology ETFs And Funds: How Do They Compare After Sell-Off? Update- 1

Update May 30-Fidelity Select Biotech (FBIOX) Fund is lagging Top ETFs FBT and IBB Compared to 2013 when FIDO  beat the  ETFs it is lagging post February bubble and YTD. It would be difficult to analyze why this happened but my guess is that: FIDO went chasing “bubble” stocks like AEGR, ICPT and was overweight […]

Continue Reading 0

No Confirmed Trading Bottom In Biotech Yet: Biotech ETF Review..Update-1

Update at Close 4/15….. Late Day Reversal To Green The NASDAQ Composite began a rally at 1P EDT and never stopped , moving up 62 points to close at 4034. Biotech ETFs followed step by step to end up in the green after a severe daily decline. The IBB ($217.6) ended up 1% after hitting […]

Continue Reading 0

Biotech Sell-Off Resumes: Caution Update 4/4

Update 4/4/14 Breach of Technicals-A Tad Below Early February Support Glut of Biotech IPOs Causing Indigestion? Momentum Days Are So Over NASDAQ Down 1.34% The volatile and speculative SPDR S&P Biotech XBI hit $136 in early trading down 2.28%.After a brief rally early this week to the $148 level volume picked up with sellers. The […]

Continue Reading 0

Alert: Broad Biotech Sell-Off of 4-5% ..ALXN, BMRN, GILD, INCY, VRTX, XBI… Update 3/23

Biotech Stocks Will Need To Rebuild Confidence With Momentum Gone Damage on Friday 3/21 was considerable but most indices/ETFs are above 2014 Feb 6 low: FBIOX ($206.4) Up 13.6% YTD, FEB 5 low $196.24 IBB ($246)  Up 8.35% YTD, FEB 6 low $237. PBE ($43.33) Up 16.94% YTD, FEB 5 low $40.32 XBI ($153) Up 17.6% […]

Continue Reading 0